EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Endocrine dysfunction induced by anti-PD-1 antibody and tyrosine kinase inhibitor in a pediatric patient with renal cell carcinoma

Megumi Endo, Shuntaro Morikawa, Naoya Kaneko, Nozomi Hishimura, Liu Zhitong, Takeshi Yamaguchi, Atsushi Yamaguchi, Hisato Segoe, Jutaro Abe, Kazumi Oura, Yukayo Terashita, Yuko Cho und 2 weitere

Clinical Pediatric Endocrinology · 2026 · 35 (3) · 260-265

DOI: 10.1297/cpe.2025-0043 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Pediatric Endocrinology, 2026. Verfasst von Megumi Endo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

adrenal insufficiencyendocrine dysfunctionhypothyroidismimmune checkpoint inhibitorstyrosine kinase inhibitors

Autor:innen und Institutionen

  • Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Center for Environmental and Health Sciences, Hokkaido University, Sapporo, Japan.
  • Department of Pharmacy, Hokkaido University Hospital, Sapporo, Japan.
  • Center for Medical Support of Transition from Children to Adult Services, Hokkaido University Hospital, Sapporo, Japan.

Zitieren

APA

Endo, M., Morikawa, S., Kaneko, N., Hishimura, N., Zhitong, L., Yamaguchi, T., Yamaguchi, A., Segoe, H., Abe, J., Oura, K., Terashita, Y., Cho, Y., Hirabayashi, S., & Manabe, A. (2026). Endocrine dysfunction induced by anti-PD-1 antibody and tyrosine kinase inhibitor in a pediatric patient with renal cell carcinoma. Clinical Pediatric Endocrinology, 35(3), 260-265. https://doi.org/10.1297/cpe.2025-0043

Vancouver

Endo M, Morikawa S, Kaneko N, Hishimura N, Zhitong L, Yamaguchi T, et al. Endocrine dysfunction induced by anti-PD-1 antibody and tyrosine kinase inhibitor in a pediatric patient with renal cell carcinoma. Clinical Pediatric Endocrinology. 2026;35(3):260-265. doi:10.1297/cpe.2025-0043

BibTeX
@article{Endo2026,
  author = {Endo, Megumi and Morikawa, Shuntaro and Kaneko, Naoya and Hishimura, Nozomi and Zhitong, Liu and Yamaguchi, Takeshi and Yamaguchi, Atsushi and Segoe, Hisato and Abe, Jutaro and Oura, Kazumi and Terashita, Yukayo and Cho, Yuko and Hirabayashi, Shinsuke and Manabe, Atsushi},
  title = {Endocrine dysfunction induced by anti-PD-1 antibody and tyrosine kinase inhibitor in a pediatric patient with renal cell carcinoma},
  journal = {Clinical Pediatric Endocrinology},
  year = {2026},
  volume = {35},
  number = {3},
  pages = {260--265},
  doi = {10.1297/cpe.2025-0043}
}
Kostenlos starten →